more>SIPCD Snapshots

Invited Speakers

Hamid Ghandehari (Keynote Speaker)


Hamid Ghandehari, PhD


Professor of Pharmaceutics

and Bioengineering

Nano Institute of Utah

University of Utah

Salt Lake City, Utah, USA


Group Website:


Hamid Ghandehari is a Professor at the Departments of Bioengineering and Pharmaceutics and Pharmaceutical Chemistry, Director of Utah Center for Nanomedicine and Co-Founder and Co-Director of the Nano Institute of Utah at the University of Utah. His research focuses on the design of new polymers for gene therapy of head and neck cancer, targeted delivery of polymer therapeutics to solid tumors, oral delivery of chemotherapeutics, and assessing the biocompatibility of silica and dendritic nanoconstructs. Dr. Ghandehari is Editor in Chief of Advanced Drug Delivery Reviews, Fellow of the American Institute for Medical and Biological Engineering, the American Association of Pharmaceutical Scientists and the Controlled Release Society. He has published over 150 articles, and given over 200 invited talks. He received his BS in Pharmacy and PhD in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah.


Representative Recent Publications

 [1] In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy. Price R, Poursaid A, Cappello J, Ghandehari H. J Control Release. 2015 Jun 18;213:96-102.

[2] In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization. Poursaid A, Price R, Tiede A, Olson E, Huo E, McGill L, Ghandehari H, Cappello J. Biomaterials. 2015 Jul;57:142-52.

[3] Macrophage silica nanoparticle response is phenotypically dependent. Herd HL, Bartlett KT, Gustafson JA, McGill LD, Ghandehari H. Biomaterials. 2015 Jun;53:574-82.

[4] Transepithelial transport of PAMAM dendrimers across isolated human intestinal tissue. Hubbard D, Enda M, Bond T, Moghaddam SP, Conarton J, Scaife C, Volckmann E, Ghandehari H. Mol Pharm. 2015 Oct 12. [Epub ahead of print]

[5] Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. Larson N, Gormley A, Frazier N, Ghandehari H. J Control Release. 2013 Aug 28;170(1):41-50.


Soochow University Biomedical Polymers Laboratory 
199 Ren-Ai Road, Suzhou Industrial Park, Suzhou 215123, China